Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bortezomib restrains M2 polarization and reduces CXCL16-associated CXCR6+CD4 T cell chemotaxis in bleomycin-induced pulmonary fibrosis. | Mol Med | 2024 | 38789926 | PubTator, text mining | PubMed |
| Stratifying risk of disease in haematuria patients using machine learning techniques to improve diagnostics. | Front Oncol | 2024 | 38779086 | PubTator, text mining | PubMed |
| CXCL16-dependent scavenging of oxidized lipids by islet macrophages promotes differentiation of pathogenic CD8+ T cells in diabetic autoimmunity. | Immunity | 2024 | 38754432 | PubTator, text mining | PubMed |
| Single-cell transcriptome reveals highly complement activated microglia cells in association with pediatric tuberculous meningitis. | Front Immunol | 2024 | 38745656 | PubTator, text mining | PubMed |
| The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management. | Cell Mol Biol Lett | 2024 | 38745115 | PubTator, text mining | PubMed |
| Prognostic value of RNF113A shows a correlation with immune infiltrates in colorectal cancer. | Am J Transl Res | 2024 | 38715816 | PubTator, text mining | PubMed |
| LGR6 is a prognostic biomarker for less differentiated tumors in lymph nodes of colon cancer patients. | Front Oncol | 2024 | 38715790 | PubTator, text mining | PubMed |
| CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy. | J Exp Clin Cancer Res | 2024 | 38698468 | PubTator, text mining | PubMed |
| Alpha 7 Nicotinic Acetylcholine Receptor Agonist PHA 568487 Reduces Acute Inflammation but Does Not Affect Cardiac Function or Myocardial Infarct Size in the Permanent Occlusion Model. | Int J Mol Sci | 2024 | 38674000 | PubTator, text mining | PubMed |
| Clinical characteristics and changes in serum CXCL10 and CXCL16 levels in patients with severe mycoplasma pneumonia. | Medicine (Baltimore) | 2024 | 38640272 | PubTator, text mining | PubMed |
| The role of the CXCR6/CXCL16 axis in the pathogenesis of fibrotic disease. | Int Immunopharmacol | 2024 | 38608478 | PubTator, text mining | PubMed |
| Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection. | Front Immunol | 2024 | 38510248 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals the potential crosstalk genes and immune relationship between Crohn's disease and atrial fibrillation. | J Thorac Dis | 2024 | 38505024 | PubTator, text mining | PubMed |
| CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. | Sci Signal | 2024 | 38502733 | PubTator, text mining | PubMed |
| Traditional Chinese Medicine Shi-Bi-Man ameliorates psoriasis via inhibiting IL-23/Th17 axis and CXCL16-mediated endothelial activation. | Chin Med | 2024 | 38429819 | PubTator, text mining | PubMed |
| The inhibitory effect of DIF-3 on polyinosinic-polycytidylic acid-induced innate immunity activation in human cerebral microvascular endothelial cells. | J Pharmacol Sci | 2024 | 38395516 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk RNA sequencing data reveals the association between hypoxic tumor cells and exhausted T cells in predicting immune therapy response. | Comput Biol Med | 2024 | 38394803 | PubTator, text mining | PubMed |
| Evaluation of interleukins (IL-1α, IL-1Ra, IL-12, IL-17A, IL-31, and IL-33) and chemokines (CXCL10 and CXCL16) in the serum of male patients with ankylosing spondylitis. | Int Immunopharmacol | 2024 | 38364743 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease. | Arterioscler Thromb Vasc Biol | 2024 | 38357816 | PubTator, text mining | PubMed |
| Sodium butyrate restricts neutrophils migration and NETs formation through reducing macrophage-derived CXCL16 in calculous cholecystitis. | Heliyon | 2024 | 38322881 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=13